Drug Profile
SGI 1776
Alternative Names: SGI-1776Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator SuperGen
- Class Amines; Imidazoles; Piperidines; Pyridazines; Small molecules
- Mechanism of Action Protein-serine-threonine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Acute myeloid leukaemia; Non-Hodgkin's lymphoma; Prostate cancer; Renal cancer
Most Recent Events
- 11 Nov 2010 Discontinued - Phase-I for hormone refractory Prostate cancer in USA (PO)
- 11 Nov 2010 Discontinued - Phase-I for hormone refractory Prostate cancer in United Kingdom (PO)
- 11 Nov 2010 Discontinued - Phase-I for recurrent Non-Hodgkin's lymphoma in United Kingdom (PO)